IBM (IBM.US) Throws Cold Water on Q4, Sparking Bull-Bear Debate: Is It a "One-Time Catch-Up" of Deferred Orders, or the Starting Point of a Software Transformation Trend?

Notice that IBM (IBM.US) fell about 5% in premarket trading on Thursday. Although the company's third-quarter revenue and earnings both exceeded market expectations, management's decision to keep its full-year guidance unchanged has left Wall Street divided on growth momentum for the fourth quarter and 2026, with investment bank views clearly splitting into bullish and cautious camps. Earnings data show that IBM's third-quarter revenue growth accelerated to 6% at constant currency, with the software business the biggest highlight: software revenue rose 9% year over year at constant currency, a marked acceleration from 5% in the previous quarter. By segment, Transaction Processing (TP), which covers mainframe system software, grew 10% as customers completed about two-thirds of the large orders deferred from the second quarter; Red Hat revenue rose 11%; and the Data business grew 20%. Despite the strong quarterly figures, IBM maintained its forecast for full-year 2026 revenue growth of 4% to 5% at constant currency and expects full-year free cash flow to increase by more than $1 billion from last year. Chief Executive Arvind Krishna acknowledged that the quarter included both purchases deferred from the second quarter and the normal third-quarter purchasing cycle, that double-digit TP growth would be difficult to sustain and would return to a normalized pace, and that fourth-quarter growth could slow from the third quarter. Cautious camp: "Unchanged" guidance exposes hidden concerns about a fourth-quarter slowdown Investment bank Susquehanna believes maintaining guidance is equivalent to signaling fourth-quarter weakness. Analyst James Friedman noted that with quarterly revenue growth already accelerated to 6%, management still anchored its 2026 revenue guidance at 4% to 5% and used the low end of the range as its base case, which mathematically implies a clear deceleration in fourth-quarter revenue. In other words, the third-quarter beat came partly from a catch-up of orders deferred from the second quarter, not from an acceleration in new demand. The firm raised its target price to $256 from $235 but maintained a "Neutral" rating, mainly because IBM's overall growth remains slower than that of S&P index constituents and the valuation lacks sufficient upside elasticity. Morgan Stanley: Whether two-digit growth can be sustained in 2027 is the key test. Morgan Stanley analysts believe the real question the market needs to answer is not about the present but about next yearwhether the software business can extend its rebound into fiscal 2027 and maintain growth close to double digits. The firm stressed in particular that this requires IBM to deliver more solid and broader organic execution in its Automation and Data businesses rather than relying on book growth from M&A consolidation. Morgan Stanley slightly raised its target price to $240 from $238 and maintained an "Equal-weight" rating, a cautious and neutral stance. Bullish camp: M&A integration is paying off, and the software transformation thesis is unchanged Well-known tech analyst Dan Ives said this is a step toward answering investors' core question. Since the Confluent and HashiCorp acquisitions closed, investors have been asking whether IBM can turn its acquisition-heavy software portfolio into faster organic growth without sacrificing margins. Ives believes the broad recovery in third-quarter software (TP +10%, Red Hat +11%, Data +20%) is an initial positive answer to that question. He maintained an "Outperform" rating and a $275 target price, betting that synergies from acquired assets will gradually materialize. Investment bank Jefferies raised its target price to $280, one of the highest on Wall Street. Jefferies lifted its IBM target price by $10 to $280, showing stronger confidence in the durability of the software rebound. The firm leans toward the view that M&A integration, continued Red Hat expansion, and AI-driven demand in the Data business will be enough to support IBM in sustaining actual growth above its guidance range for several quarters. The essence of the disagreement: a "pulse" or a "trend"? Taken together, the cautious and bullish camps differ on one point: whether the strong third-quarter software growth is a one-time pulse from deferred-order catch-up and M&A consolidation, or an organic trend that can extend into 2027. Management's decision to keep full-year guidance unchanged and the CEO's deliberate attempt to temper expectations have undoubtedly strengthened the cautious camp's case. The fourth-quarter earnings report will be a key validation windowif software growth slows to single digits as expected, the stock price may remain under pressure; if the Automation and Data businesses can independently carry double-digit growth, only then can the bullish camp's valuation-recovery thesis truly materialize.